0001944425-22-000007.txt : 20220927 0001944425-22-000007.hdr.sgml : 20220927 20220926173251 ACCESSION NUMBER: 0001944425-22-000007 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220927 DATE AS OF CHANGE: 20220926 EFFECTIVENESS DATE: 20220927 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Blue Elephant Medical Device Fund, LP CENTRAL INDEX KEY: 0001823133 IRS NUMBER: 852147928 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-377373 FILM NUMBER: 221266860 BUSINESS ADDRESS: STREET 1: 3 WEST MAIN STREET STREET 2: SUITE 301 CITY: IRVINGTON STATE: NY ZIP: 10533 BUSINESS PHONE: (914) 274-8483 MAIL ADDRESS: STREET 1: 3 WEST MAIN STREET STREET 2: SUITE 301 CITY: IRVINGTON STATE: NY ZIP: 10533 D/A 1 primary_doc.xml X0708 D/A LIVE 0001823133 Blue Elephant Medical Device Fund, LP 3 WEST MAIN STREET SUITE 301 IRVINGTON NY NEW YORK 10533 (914) 274-8483 DELAWARE None None Limited Partnership true 2020 Ashees N/A Jain 3 West Main Street Suite 301 Irvington NY NEW YORK 10533 Executive Officer Promoter Manager of the Investment Manager of the Issuer. Joseph P. Marra 3 West Main Street Suite 301 Irvington NY NEW YORK 10533 Executive Officer Promoter Manager of the Investment Manager of the Issuer. N/A N/A Blue Elephant Partners, LLC 3 West Main Street Suite 301 Irvington NY NEW YORK 10533 Promoter General Partner of the Issuer. N/A N/A Blue Elephant Capital Management, LLC 3 West Main Street Suite 301 Irvington NY NEW YORK 10533 Promoter Investment Manager of the Issuer. Pooled Investment Fund Other Investment Fund false Decline to Disclose 06b true 0001877142-21-000005 2020-09-24 false true false 500000 Indefinite 19425000 Indefinite false 33 0 true 0 true 70062 true Organizational Expenses will be reimbursed to the General Partner and Investment Manager. A management fee will be paid to the Investment Manager in accordance with the Issuer's offering documents. false Blue Elephant Medical Device Fund, LP Dave Lemma Dave Lemma Chief Compliance Officer 2022-09-26